Follow the people · Insider
Peter M. Neupert
Peter M. Neupert files insider transactions with the SEC as a director of Adaptive Biotechnologies (ADPT). We hold 1 disclosed purchase or sale filed since 12 May 2006, 1 of them in the last 90 days.
- Files forADPT
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure19 August 2026
Positions held
5 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 13 February 2020 — 17 August 2026Director · Adaptive Biotechnologies (ADPT)25 Form 4 lines · source: SEC Form 4
- Filed 18 July 2023 — 10 June 2026Chief Executive Officer · Fortrea Holdings (FTRE)13 Form 4 lines · source: SEC Form 4
- Filed 2 January 2013 — 11 February 2026Director · Laboratory Corp Of America (LH)47 Form 4 lines · source: SEC Form 4
- Filed 15 August 2013 — 15 August 2013Director · Quality Systems (QSII)1 Form 4 line · source: SEC Form 4
- Filed 10 May 2006 — 10 May 2006Director · Aquantive (AQNT)1 Form 4 line · source: SEC Form 4
Everything they disclosed
87 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 15,000 shares of Adaptive BiotechnologiesSEC Form 419 August 2026Common Stock · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 15,000 shares of Adaptive BiotechnologiesSEC Form 419 August 2026Common Stock · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 40,000 shares of Adaptive BiotechnologiesSEC Form 419 August 2026Common Stock · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 69,690 shares of Adaptive BiotechnologiesSEC Form 419 August 2026Common Stock · traded 17 August 2026 · filed 19 August 2026
- exercised options over 15,000 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 419 August 2026Stock Option (right to buy) · traded 17 August 2026 · filed 19 August 2026
- was granted 12,852 shares of Fortrea Holdings (a derivative holding)SEC Form 412 June 2026Restricted Stock Unit · traded 10 June 2026 · filed 12 June 2026
- exercised options over 148,536 shares of Fortrea HoldingsSEC Form 418 May 2026Common Stock · traded 14 May 2026 · filed 18 May 2026
- exercised options over 148,536 shares of Fortrea Holdings (a derivative holding)SEC Form 418 May 2026Restricted Stock Unit · traded 14 May 2026 · filed 18 May 2026
- was granted 15,625 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- was granted 15,625 shares of Adaptive BiotechnologiesSEC Form 46 March 2026Common Stock · traded 4 March 2026 · filed 6 March 2026
- exercised options over 897 shares of Labcorp HoldingsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- exercised options over 897 shares of Labcorp Holdings (a derivative holding)SEC Form 413 February 2026Restricted Stock Unit · traded 11 February 2026 · filed 13 February 2026
- exercised options over 897 shares of Labcorp Holdings (a derivative holding)SEC Form 413 February 2026Restricted Stock Unit · traded 11 February 2026 · filed 13 February 2026
- exercised options over 897 shares of Labcorp HoldingsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- was granted 773 shares of Labcorp Holdings (a derivative holding)SEC Form 412 February 2026Restricted Stock Unit · traded 10 February 2026 · filed 12 February 2026
- was granted 773 shares of Labcorp Holdings (a derivative holding)SEC Form 412 February 2026Restricted Stock Unit · traded 10 February 2026 · filed 12 February 2026
- ▲ bought on the open market 30,000 shares of Fortrea HoldingsSEC Form 411 August 2025Common Stock · traded 8 August 2025 · filed 11 August 2025
- ▲ bought on the open market 32,500 shares of Fortrea HoldingsSEC Form 411 August 2025Common Stock · traded 11 August 2025 · filed 11 August 2025
- exercised options over 7,282 shares of Fortrea Holdings (a derivative holding)SEC Form 416 May 2025Restricted Stock Unit · traded 14 May 2025 · filed 16 May 2025
- was granted 148,536 shares of Fortrea Holdings (a derivative holding)SEC Form 416 May 2025Restricted Stock Unit · traded 14 May 2025 · filed 16 May 2025
- exercised options over 7,282 shares of Fortrea HoldingsSEC Form 416 May 2025Common Stock · traded 14 May 2025 · filed 16 May 2025
- exercised options over 50,000 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 412 March 2025Stock Option (right to buy) · traded 10 March 2025 · filed 12 March 2025
- exercised options over 50,000 shares of Adaptive BiotechnologiesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- ▼ sold on the open market 10,000 shares of Adaptive BiotechnologiesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- was granted 23,726 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 March 2025Stock Option (right to buy) · traded 4 March 2025 · filed 6 March 2025
- was granted 15,394 shares of Adaptive BiotechnologiesSEC Form 46 March 2025Common Stock · traded 4 March 2025 · filed 6 March 2025
- was granted 897 shares of Labcorp Holdings (a derivative holding)SEC Form 413 February 2025Restricted Stock Unit · traded 11 February 2025 · filed 13 February 2025
- exercised options over 944 shares of Labcorp Holdings (a derivative holding)SEC Form 410 February 2025Restricted Stock Unit · traded 6 February 2025 · filed 10 February 2025
- exercised options over 944 shares of Labcorp HoldingsSEC Form 410 February 2025Common Stock · traded 6 February 2025 · filed 10 February 2025
- exercised options over 6,354 shares of Fortrea Holdings (a derivative holding)SEC Form 419 July 2024Restricted Stock Unit · traded 18 July 2024 · filed 19 July 2024
- exercised options over 6,354 shares of Fortrea HoldingsSEC Form 419 July 2024Common Stock · traded 18 July 2024 · filed 19 July 2024
- was granted 7,282 shares of Fortrea Holdings (a derivative holding)SEC Form 416 May 2024Restricted Stock Unit · traded 14 May 2024 · filed 16 May 2024
- exercised options over 15,000 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 413 March 2024Stock Option (right to buy) · traded 12 March 2024 · filed 13 March 2024
- exercised options over 15,000 shares of Adaptive BiotechnologiesSEC Form 413 March 2024Common Stock · traded 12 March 2024 · filed 13 March 2024
- was granted 48,044 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 46 March 2024Stock Option (right to buy) · traded 4 March 2024 · filed 6 March 2024
- was granted 31,328 shares of Adaptive BiotechnologiesSEC Form 46 March 2024Common Stock · traded 4 March 2024 · filed 6 March 2024
- was granted 944 shares of Laboratory Corp Of America (a derivative holding)SEC Form 48 February 2024Restricted Stock Unit · traded 6 February 2024 · filed 8 February 2024
- exercised options over 947 shares of Laboratory Corp Of America (a derivative holding)SEC Form 48 February 2024Restricted Stock Unit · traded 7 February 2024 · filed 8 February 2024
- exercised options over 947 shares of Laboratory Corp Of AmericaSEC Form 48 February 2024Common Stock · traded 7 February 2024 · filed 8 February 2024
- exercised options over 100,000 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 415 December 2023Stock Option (right to buy) · traded 13 December 2023 · filed 15 December 2023
- exercised options over 100,000 shares of Adaptive BiotechnologiesSEC Form 415 December 2023Common Stock · traded 13 December 2023 · filed 15 December 2023
- ▲ bought on the open market 11,000 shares of Fortrea HoldingsSEC Form 423 August 2023Common Stock · traded 23 August 2023 · filed 23 August 2023
- was granted 6,354 shares of Fortrea Holdings (a derivative holding)SEC Form 419 July 2023Restricted Stock Unit · traded 18 July 2023 · filed 19 July 2023
- was granted 23,329 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 48 March 2023Stock Option (right to buy) · traded 6 March 2023 · filed 8 March 2023
- was granted 14,775 shares of Adaptive BiotechnologiesSEC Form 48 March 2023Common Stock · traded 6 March 2023 · filed 8 March 2023
- exercised options over 742 shares of Laboratory Corp Of America (a derivative holding)SEC Form 414 February 2023Restricted Stock Unit · traded 11 February 2023 · filed 14 February 2023
- exercised options over 742 shares of Laboratory Corp Of AmericaSEC Form 414 February 2023Common Stock · traded 11 February 2023 · filed 14 February 2023
- was granted 849 shares of Laboratory Corp Of America (a derivative holding)SEC Form 49 February 2023Restricted Stock Unit · traded 7 February 2023 · filed 9 February 2023
- ▲ bought on the open market 1,300 shares of Laboratory Corp Of AmericaSEC Form 418 February 2022Common Stock · traded 16 February 2022 · filed 18 February 2022
- ▲ bought on the open market 1,600 shares of Laboratory Corp Of AmericaSEC Form 418 February 2022Common Stock · traded 16 February 2022 · filed 18 February 2022
- ▲ bought on the open market 600 shares of Laboratory Corp Of AmericaSEC Form 418 February 2022Common Stock · traded 16 February 2022 · filed 18 February 2022
- was granted 742 shares of Laboratory Corp Of America (a derivative holding)SEC Form 415 February 2022Restricted Stock Unit · traded 11 February 2022 · filed 15 February 2022
- exercised options over 771 shares of Laboratory Corp Of America (a derivative holding)SEC Form 44 February 2022Restricted Stock Unit · traded 2 February 2022 · filed 4 February 2022
- exercised options over 771 shares of Laboratory Corp Of AmericaSEC Form 44 February 2022Common Stock · traded 2 February 2022 · filed 4 February 2022
- was granted 16,722 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 428 January 2022Stock Option (Right to Buy) · traded 26 January 2022 · filed 28 January 2022
- was granted 6,689 shares of Adaptive BiotechnologiesSEC Form 428 January 2022Common Stock · traded 26 January 2022 · filed 28 January 2022
- was granted 1,504 shares of Adaptive BiotechnologiesSEC Form 417 February 2021Common Stock · traded 14 February 2021 · filed 17 February 2021
- was granted 3,759 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 417 February 2021Stock Option (Right to Buy) · traded 14 February 2021 · filed 17 February 2021
- exercised options over 986 shares of Laboratory Corp Of AmericaSEC Form 48 February 2021Common Stock · traded 4 February 2021 · filed 8 February 2021
- exercised options over 986 shares of Laboratory Corp Of America (a derivative holding)SEC Form 48 February 2021Restricted Stock Unit · traded 4 February 2021 · filed 8 February 2021
- was granted 771 shares of Laboratory Corp Of America (a derivative holding)SEC Form 44 February 2021Restricted Stock Unit · traded 2 February 2021 · filed 4 February 2021
- was granted 8,888 shares of Adaptive Biotechnologies (a derivative holding)SEC Form 418 February 2020Stock Option (Right to Buy) · traded 13 February 2020 · filed 18 February 2020
- exercised options over 1,227 shares of Laboratory Corp Of America (a derivative holding)SEC Form 414 February 2020Restricted Stock Unit · traded 12 February 2020 · filed 14 February 2020
- exercised options over 1,227 shares of Laboratory Corp Of AmericaSEC Form 414 February 2020Common Stock · traded 12 February 2020 · filed 14 February 2020
- was granted 986 shares of Laboratory Corp Of America (a derivative holding)SEC Form 46 February 2020Restricted Stock Unit · traded 4 February 2020 · filed 6 February 2020
- exercised options over 1,038 shares of Laboratory Corp Of America (a derivative holding)SEC Form 414 February 2019Restricted Stock Unit · traded 12 February 2019 · filed 14 February 2019
- was granted 1,227 shares of Laboratory Corp Of America (a derivative holding)SEC Form 414 February 2019Restricted Stock Unit · traded 12 February 2019 · filed 14 February 2019
- exercised options over 1,038 shares of Laboratory Corp Of AmericaSEC Form 414 February 2019Common Stock · traded 12 February 2019 · filed 14 February 2019
- was granted 1,038 shares of Laboratory Corp Of America (a derivative holding)SEC Form 414 February 2018Restricted Stock Unit · traded 12 February 2018 · filed 14 February 2018
- exercised options over 1,263 shares of Laboratory Corp Of America (a derivative holding)SEC Form 49 February 2018Restricted Stock Unit · traded 7 February 2018 · filed 9 February 2018
- exercised options over 1,263 shares of Laboratory Corp Of AmericaSEC Form 49 February 2018Common Stock · traded 7 February 2018 · filed 9 February 2018
- exercised options over 1,560 shares of Laboratory Corp Of AmericaSEC Form 413 February 2017Common Stock · traded 9 February 2017 · filed 13 February 2017
- exercised options over 1,560 shares of Laboratory Corp Of America (a derivative holding)SEC Form 413 February 2017Restricted Stock Unit · traded 9 February 2017 · filed 13 February 2017
- was granted 1,263 shares of Laboratory Corp Of America (a derivative holding)SEC Form 49 February 2017Restricted Stock Unit · traded 7 February 2017 · filed 9 February 2017
- exercised options over 1,237 shares of Laboratory Corp Of AmericaSEC Form 415 March 2016Common Stock · traded 11 March 2016 · filed 15 March 2016
- exercised options over 1,237 shares of Laboratory Corp Of America (a derivative holding)SEC Form 415 March 2016Restricted Stock Unit · traded 11 March 2016 · filed 15 March 2016
- was granted 1,560 shares of Laboratory Corp Of America (a derivative holding)SEC Form 411 February 2016Restricted Stock Unit · traded 9 February 2016 · filed 11 February 2016
- was granted 1,237 shares of Laboratory Corp Of America (a derivative holding)SEC Form 413 March 2015Restricted Stock Unit · traded 11 March 2015 · filed 13 March 2015
- exercised options over 1,503 shares of Laboratory Corp Of AmericaSEC Form 412 February 2015Common Stock · traded 10 February 2015 · filed 12 February 2015
- exercised options over 1,503 shares of Laboratory Corp Of America (a derivative holding)SEC Form 412 February 2015Restricted Stock Unit · traded 10 February 2015 · filed 12 February 2015
- was granted 1,503 shares of Laboratory Corp Of America (a derivative holding)SEC Form 415 May 2014Restricted Stock Unit · traded 13 May 2014 · filed 15 May 2014
- exercised options over 1,593 shares of Laboratory Corp Of AmericaSEC Form 412 May 2014Common Stock · traded 8 May 2014 · filed 12 May 2014
- exercised options over 1,593 shares of Laboratory Corp Of America (a derivative holding)SEC Form 412 May 2014Restricted Stock Unit · traded 8 May 2014 · filed 12 May 2014
- was granted 3,836 shares of Quality SystemsSEC Form 419 August 2013Common Stock · traded 15 August 2013 · filed 19 August 2013
- was granted 1,593 shares of Laboratory Corp Of America (a derivative holding)SEC Form 416 May 2013Restricted Stock Unit · traded 8 May 2013 · filed 16 May 2013
- was granted 575 shares of Laboratory Corp Of AmericaSEC Form 416 January 2013Common Stock · traded 2 January 2013 · filed 16 January 2013
- was granted 15,000 shares of Aquantive (a derivative holding)SEC Form 412 May 2006Stock Option (Right to Buy) · traded 10 May 2006 · filed 12 May 2006
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.